Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 2002;8(6):329–332. doi: 10.1155/MBD.2002.329

Synthesis and “in Vitro” Trypanocidal Activity Evaluation of Some Organo-iron Compounds.

Máfircio L A e Silva 1,2,✉, Alberto F Neto 3, Silvia A Cardoso 3, Sérgio Albuquerque 4, Joseph Miller 5
PMCID: PMC2365288  PMID: 18476014

Abstract

Eight organo-iron ferrocene derivatives and arenocenium salts were prepared and evaluated by “in vitro” assay against one strain of Trypanosoma cruzi (Y). Six of the eight organo-iron compounds assayed, piperazinium diferrocenoate 1, η6-(o-xylene)-η5-(cyclopentadienyl) Iron(II) hexafluorophosphate 3, η6-(mesitylene)-η5-(cyclopentadienyl) iron(II) hexafluorphosphate 5, η6-(durene)-η5-(cyclopentadienyl) iron(II) hexafluorphosphate 6, η6-(ρ-chlorotoluene)-η5-(cyclopentadienyl) Iron(II) hexafluorphosphate 7 and η6-(chlorobenzene)-η5-(cyclopentadienyl) iron(II) picrate 8 , were poorly active in the “in vitro” assays. Only two compounds 1,1'–(N-pyperidinocarbonyl) ferrocene 2(IC50=2.4 μg/mL) and η6-(o-xylene)-η5(cyclopentadienyl) iron(II) picrate 4 (IC50=12.08 μg/mL), were more active. Thus, some of the compounds are promising to be used against Chagas' disease as a prophylactic agents.

Full Text

The Full Text of this article is available as a PDF (565.8 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES